A major advance in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This vital malignant protector protein is frequently disabled in many forms of malignancies, leading uncontrolled https://socialskates.com/story23425076/nanobodies-reactivate-p53-a-new-hope-for-malignant-treatment